Jarrett Jennifer bought RCUS
January 23, 2026 · Form 4 insider transaction
Jarrett Jennifer bought 126,000 shares of Arcus Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
126,000
Price
$0.00
Total value
N/A
InsiderJarrett Jennifer
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJanuary 23, 2026
Filing dateJanuary 26, 2026
Shares owned after126,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option becomes exercisable in 48 equal monthly installments after January 1, 2026, subject to the Reporting Person's continued service to the Company.